| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
| Expenses | 2 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 1 |
| EBITDA | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 9 % | 12 % | 10 % | 11 % | 12 % | 13 % | 1 % | 2 % | 0 % | 2 % | -4 % | -2 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS in ₹ | 0.00 | 0.12 | 0.18 | 0.23 | 0.46 | 0.46 | 0.05 | 0.09 | 0.10 | 0.11 | 0.16 | 0.10 |
Ganga Pharmaceuticals
Ganga Pharmaceuticals
14.60
-14.60
(-100.00%)
Key Fundamentals
Market Cap
9.90 Cr
EPS
0.16
PE Ratio
488.20
Dividend Yield
0.00 %
Industry
Healthcare 52 Week High
19.20
52 Week Low
9.25
PB Ratio
1.10
Debt to Equity
0.20
Sector
Pharmaceuticals Actual
Company News
View All News
Ganga Pharmaceuticals Reports Net Profit of Rs 2.48 Lakhs for Half-Year Ended September 2025
Nov 07, 2025
Nov 07, 2025Ganga Pharmaceuticals Limited announced its unaudited financial results for the half-year ended September 30, 2025. The company reported revenue from operations of Rs 136.65 lakhs compared to Rs 263.74 lakhs in the previous year. Net profit for the period was Rs 2.48 lakhs versus Rs 7.90 lakhs in the corresponding previous period. Basic earnings per share stood at Rs 0.08 compared to Rs 0.16 in the previous year. During the reporting period, the company converted 10,75,000 warrants into equity shares, raising Rs 112.88 lakhs. The paid-up equity share capital increased to Rs 5,91,15,000 following the conversion. Out of the funds raised, Rs 53.48 lakhs has been utilized for stated purposes with the balance kept in bank accounts. The remaining 7,00,000 warrants were forfeited as warrant holders did not remit the balance consideration within the prescribed time.
Plutus Capital Management Acquires 7.75% Stake in Ganga Pharmaceuticals Through Warrant ConversionSep 19, 2025
Sep 19, 2025Plutus Capital Management LLP acquired 375,000 shares in Ganga Pharmaceuticals Ltd, representing a 7.75% stake in the company. The acquisition occurred through the conversion of convertible warrants into equity shares on July 17, 2025. Prior to this transaction, Plutus Capital held no shares in the company. The acquisition increased Ganga Pharmaceuticals' total equity share capital from Rs. 4.84 crore to Rs. 5.91 crore, with the total number of equity shares rising from 48.37 lakh to 59.12 lakh shares of Rs. 10 each. Plutus Capital Management is not part of the promoter group. The company's shares are listed on BSE Limited under scrip code 539680.
Plutus Capital Management Acquires 7.75% Stake in Ganga Pharmaceuticals Through Warrant ConversionAug 05, 2025
Aug 05, 2025Plutus Capital Management LLP acquired a 7.75% stake in Ganga Pharmaceuticals Ltd by purchasing 3,75,000 shares through the conversion of convertible warrants. The acquisition was completed through preferential allotment on July 17, 2025. Prior to this transaction, Plutus Capital held no shares in the company. The acquisition increased Ganga Pharmaceuticals' equity share capital from Rs. 4,83,65,000 (48,36,500 shares) to Rs. 5,91,15,000 (59,11,500 shares). Plutus Capital Management is not part of the promoter group. The company's shares are listed on BSE Limited.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,784.10 | #1 4,28,065.35 | 40.27 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 74.53 | |
6,454.00 | 1,71,333.42 | 69.17 | 9,712.00 | 18.67 | 2,191 | 35.10 | 46.81 | |
3,731.40 | 1,26,287.53 | 59.99 | 11,539.40 | 6.99 | 1,911 | 30.46 | 56.17 | |
1,526.80 | 1,23,327.89 | 22.52 | 28,409.50 | 7.12 | 5,291 | 3.71 | 47.29 | |
1,250.20 | 1,04,343.41 | #1 18.09 | 33,741.20 | 16.73 | 5,725 | -0.38 | 54.25 | |
930.20 | 93,599.89 | 18.57 | 23,511.00 | 18.55 | 4,615 | 34.60 | 33.90 | |
2,025.40 | 92,511.06 | 21.51 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 57.78 | |
2,223.10 | 91,760.34 | 51.75 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 29.21 | |
1,235.80 | 71,775.46 | 21.23 | 32,345.60 | 9.43 | 3,484 | 3.81 | 74.03 | |
5,724.00 | 68,439.01 | 28.33 | 13,458.30 | 3.70 | 2,216 | 10.98 | 64.07 |
Growth Rate
Revenue Growth
3.33 %
Net Income Growth
18.60 %
Cash Flow Change
53.97 %
ROE
68.18 %
ROCE
11.41 %
EBITDA Margin (Avg.)
4.10 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 5 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 9 |
| Fixed Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Current Assets | 2 | 5 | 4 | 5 | 4 | 4 | 5 | 5 | 5 | 6 | 7 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 5 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 8 |
| Total Liabilities | 5 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 9 |
| Current Liabilities | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
| Non Current Liabilities | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Total Equity | 3 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 7 | 7 |
| Reserve & Surplus | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Share Capital | 2 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | -0 | -1 | 1 | -0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| Operating Activities | 0 | -1 | 0 | 0 | 0 | -0 | -0 | -0 | 0 | -1 | -1 |
| Financing Activities | -0 | 2 | -0 | -0 | -0 | -0 | -0 | 0 | -0 | 1 | -0 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Mar 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Jun 2025 | Jul 2025 | Sept 2025 |
| Promoter | 66.71 % | 66.71 % | 66.71 % | 66.71 % | 66.71 % | 66.71 % | 66.71 % | 66.71 % | 66.71 % | 56.02 % | 56.02 % | 56.02 % | 56.02 % | 50.91 % | 50.91 % | 50.91 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 32.11 % | 32.11 % | 32.30 % | 32.30 % | 32.50 % | 32.30 % | 31.91 % | 31.91 % | 31.91 % | 35.23 % | 35.40 % | 35.23 % | 35.07 % | 35.46 % | 35.46 % | 35.32 % |
| Others | 1.18 % | 1.18 % | 0.98 % | 0.98 % | 0.79 % | 0.98 % | 1.38 % | 1.38 % | 1.38 % | 8.75 % | 8.58 % | 8.75 % | 8.91 % | 13.63 % | 13.63 % | 13.77 % |
| No of Share Holders | 354 | 354 | 354 | 354 | 356 | 356 | 355 | 356 | 359 | 362 | 363 | 365 | 368 | 367 | 367 | 366 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 04 Jan 2024 |  Extraordinary General Meeting | NA | 04 Jan 2024 | 14.36 | 27.10 |
| 25 Sept 2024 |  Annual General Meeting | NA | 25 Sept 2024 | 24.67 | 19.57 |
| 08 Nov 2024 |  Quarterly Result Announcement | NA | 08 Nov 2024 | 15.73 | 15.73 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 13.51 | 13.51 |
| 20 Sept 2025 | Annual General Meeting | NA | 20 Sept 2025 | 14.60 | 14.60 |
| 07 Nov 2025 | Quarterly Result Announcement | NA | 07 Nov 2025 | 14.60 | 14.60 |
Announcements
Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 07, 2025
Nov 07, 2025Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 07, 2025
Nov 07, 2025Un-Audited Financial Results Of The Company For The Half Year Ended On September 30 2025.Nov 07, 2025
Nov 07, 2025Board Meeting Outcome for Held On Friday November 07 2025Nov 07, 2025
Nov 07, 2025Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company For The Half Year Ended On September 30 2025Nov 03, 2025
Nov 03, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Oct 09, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 22, 2025
Sep 22, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 20, 2025
Sep 20, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 20, 2025
Sep 20, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 19, 2025
Sep 19, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 28, 2025
Aug 28, 2025Dispatch Of Letter To ShareholdersAug 26, 2025
Aug 26, 2025Reg. 34 (1) Annual Report.Aug 26, 2025
Aug 26, 2025Notice Of The 36Th Annual General Meeting Of The CompanyAug 26, 2025
Aug 26, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 20, 2025
Aug 20, 2025Corporate Action - Fixes Book Closure For (AGM)Aug 20, 2025
Aug 20, 2025Intimation For 36Th Annual General Meeting Scheduled To Be Held On Saturday September 20 2025.Aug 20, 2025
Aug 20, 2025Board Meeting Outcome for Held On Wednesday August 20 2025Aug 20, 2025
Aug 20, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 05, 2025
Aug 05, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 05, 2025
Aug 05, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 30, 2025
Jul 30, 2025Non -Exercise Of Option To Convert Of Warrants.Jul 19, 2025
Jul 19, 2025Announcement under Regulation 30 (LODR)-AllotmentJul 17, 2025
Jul 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 2025Appointment of Company Secretary and Compliance OfficerJul 01, 2025
Jul 01, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
May 28, 2025Statement Of Deviation And VariationMay 20, 2025
May 20, 2025ResultsMay 20, 2025
May 20, 2025Board Meeting Outcome for Held On May 20 2025May 20, 2025
May 20, 2025Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Half And Financial Year Ended On March 31 2025.May 06, 2025
May 06, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 22, 2025
Apr 22, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 22, 2025
Apr 22, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Apr 08, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMar 31, 2025
Mar 31, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMar 31, 2025
Mar 31, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateMar 27, 2025
Mar 27, 2025Board Meeting Outcome for Held On Thursday March 27 2025Mar 27, 2025
Mar 27, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Jan 08, 2025Statement Of Deviation For September 30, 2024Nov 08, 2024
Nov 08, 2024Un-Audited Financial Results Of The Company For The HalfYear Ended On September 30, 2024.Nov 08, 2024
Nov 08, 2024Board Meeting Outcome for For The Meeting Held On Friday, November 08, 2024Nov 08, 2024
Nov 08, 2024Board Meeting Intimation For Consider And Approve The Un-Audited Financial Results Of The Company For The Half Year Ended On September 30,2024Nov 06, 2024
Nov 06, 2024Board Meeting Intimation for Consider And Approve The Un-Audited Financial Results Of The Company For The Half Year Ended On September 30,2024Nov 05, 2024
Nov 05, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 09, 2024
Oct 09, 2024Closure of Trading WindowSep 26, 2024
Sep 26, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 25, 2024
Sep 25, 2024Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2024
Sep 25, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2024
Sep 03, 2024Technical Indicators
RSI(14)
Neutral 48.69
ATR(14)
Less Volatile 1.59
STOCH(9,6)
Overbought 88.82
STOCH RSI(14)
Overbought 92.68
MACD(12,26)
Bullish 0.54
ADX(14)
Strong Trend 38.01
UO(9)
Bearish 68.79
ROC(12)
Uptrend And Accelerating 24.89
WillR(14)
Overbought -3.60
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
